87 related articles for article (PubMed ID: 24275675)
21. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.
Hocqueloux L; Avettand-Fènoël V; Jacquot S; Prazuck T; Legac E; Mélard A; Niang M; Mille C; Le Moal G; Viard JP; Rouzioux C;
J Antimicrob Chemother; 2013 May; 68(5):1169-78. PubMed ID: 23335199
[TBL] [Abstract][Full Text] [Related]
22. Improvement in onychomycosis after initiation of combined antiretroviral therapy.
Moreno-Coutiño G; Arenas R; Reyes-Terán G
Int J Dermatol; 2013 Mar; 52(3):311-3. PubMed ID: 22998739
[TBL] [Abstract][Full Text] [Related]
23. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
24. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.
Ciccarelli N; Fabbiani M; Di Giambenedetto S; Fanti I; Baldonero E; Bracciale L; Tamburrini E; Cauda R; De Luca A; Silveri MC
Neurology; 2011 Apr; 76(16):1403-9. PubMed ID: 21502598
[TBL] [Abstract][Full Text] [Related]
25. Short communication: effects of age on virologic suppression and CD4 cell response in HIV-positive patients initiating combination antiretroviral therapy.
Szadkowski L; Tseng A; Walmsley SL; Salit I; Raboud JM
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1579-83. PubMed ID: 22734840
[TBL] [Abstract][Full Text] [Related]
26. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
27. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
[TBL] [Abstract][Full Text] [Related]
28. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
29. When and why to start antiretroviral therapy?
Gatell JM
J Antimicrob Chemother; 2010 Mar; 65(3):383-5. PubMed ID: 20071369
[TBL] [Abstract][Full Text] [Related]
30. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
[TBL] [Abstract][Full Text] [Related]
31. Will antiretroviral therapy reduce HIV-related liver risk?
Allen J; Smith C; Bhagani S
Curr Opin HIV AIDS; 2014 Jan; 9(1):48-53. PubMed ID: 24247670
[TBL] [Abstract][Full Text] [Related]
32. Antiretroviral therapy, immune suppression and renal impairment in HIV-positive persons.
Ryom L; Mocroft A; Lundgren JD
Curr Opin HIV AIDS; 2014 Jan; 9(1):41-7. PubMed ID: 24225381
[TBL] [Abstract][Full Text] [Related]
33. Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk.
Borges AH; Dubrow R; Silverberg MJ
Curr Opin HIV AIDS; 2014 Jan; 9(1):34-40. PubMed ID: 24225382
[TBL] [Abstract][Full Text] [Related]
34. The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India.
Ghate M; Mehendale S; Meyer R; Umlauf A; Deutsch R; Kamat R; Thakar M; Risbud A; Kulkarni S; Sakamoto M; Alexander T; Franklin D; Letendre S; Heaton RK; Grant I; Marcotte TD
J Neurovirol; 2015 Aug; 21(4):391-8. PubMed ID: 25750072
[TBL] [Abstract][Full Text] [Related]
35. Does antiretroviral therapy started at high CD4 cell counts reduce an individual HIV-positive patient's disease risk?
Baker JV; Sabin CA
Curr Opin HIV AIDS; 2014 Jan; 9(1):1-3. PubMed ID: 24225383
[No Abstract] [Full Text] [Related]
36. Short Communication: Hyperthyroidism in Human Immunodeficiency Virus Patients on Combined Antiretroviral Therapy: Case Series and Literature Review.
Hsu E; Phadke VK; Nguyen ML
AIDS Res Hum Retroviruses; 2016 Jun; 32(6):564-6. PubMed ID: 26887978
[TBL] [Abstract][Full Text] [Related]
37. Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy.
Schouten J; Su T; Wit FW; Kootstra NA; Caan MW; Geurtsen GJ; Schmand BA; Stolte IG; Prins M; Majoie CB; Portegies P; Reiss P;
AIDS; 2016 Apr; 30(7):1027-38. PubMed ID: 26752277
[TBL] [Abstract][Full Text] [Related]
38. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.
Cysique LA; Brew BJ
Neuropsychol Rev; 2009 Jun; 19(2):169-85. PubMed ID: 19424802
[TBL] [Abstract][Full Text] [Related]
39. Cognitive disorders in people living with HIV.
Winston A; Spudich S
Lancet HIV; 2020 Jul; 7(7):e504-e513. PubMed ID: 32621876
[TBL] [Abstract][Full Text] [Related]
40. [Progress in Antiretroviral Therapy and HAND].
Matsui Y; Takaori-Kondo A
Brain Nerve; 2015 Jul; 67(7):947-59. PubMed ID: 26160822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
